Principal Securities »

SPDR S&P Pharmaceuticals shares owned by Principal Securities

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Principal Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 605 41.64

More positions owned by Principal Securities

Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Rus 1000 Etf (IWB)
Principal Exchange Traded Prnc Invt Grad (IG)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Principal Securities

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
First Citizens Bank & Trust
Bnp Paribas Arbitrage, Snc
Envestnet Portfolio Solutions
Wharton Business Group
UBS Group
MAI Wealth Advisors
Kingsview Wealth Management
Pnc Financial Services
Royal Bank of Canada
Citadel Advisors
AE Wealth Management

View all funds holding SPDR S&P Pharmaceuticals